At Nucliq Biologics, discovery starts in the gut. By decoding the microbiome with cutting-edge AI and multi-omics science, we’re building a new therapeutic frontier one where data becomes discovery, and precision meets prevention. Here’s how our journey unfolds.
Nucliq’s Innovation Journey
At Nucliq, science meets strategy. Our journey from gut data to precision therapeutics is powered not only by AI and multi-omics, but by the brilliant minds behind the scenes bioinformaticians, microbiologists, biochemists, systems biologists, and clinical researchers working in synergy. Together, we decode the microbiome, uncover microbial signatures, and craft next-generation therapeutics designed to transform complex disease care.
Unlocking Microbial Intelligence
We harness AI, machine learning, and Gutcheck-powered analytics to decode complex microbial ecosystems revealing functional pathways and host interactions linked to health and disease.
Turning Data Into Discovery
Using a multi-omics lens including metagenomics, transcriptomics, and metabolomics we map bioactive microbial signatures and identify precision targets for therapeutic intervention.
Engineering Precision Therapeutics
From gut-derived molecules to drug candidates, Microterra AI drives the development of targeted therapies that modulate key physiological axes neuroimmune, gut-brain, and gut-skin to tackle chronic, multifactorial diseases.
Symbiosis in Science
Innovating from Microbial Blueprints
